INTEGRA LIFESCIENCES HOLDINGS CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.6 | $1.6 | $1.5 | $1.6 | $1.5 |
| Operating income | -$0.5 | $<0.1 | $0.1 | $0.2 | $0.2 |
| Net income | -$0.5 | -$<0.1 | $0.1 | $0.2 | $0.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$<0.1 | $<0.1 | $0.1 | $0.2 | $0.3 |
| Share repurchases | $<0.1 | $0.1 | $0.3 | $0.1 | $0.0 |
Shares outstanding 77.8M · Free float 98.0%
Annual filing data through FY ended December 31, 2025; float as of October 8, 2026.